Anixa Biosciences, Inc. (ANIX) vs Definitive Healthcare Corp. (DH)
A side-by-side comparison of Anixa Biosciences, Inc. and Definitive Healthcare Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIX
Anixa Biosciences, Inc.
$2.95HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
DH
Definitive Healthcare Corp.
$0.99HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ANIX vs DH
growth of $100 · dividends reinvested · last 5yANIX -40.3% (-9.8%/yr)DH -97.7% (-53.1%/yr)ANIX compounded faster over this window
Log scale — wide-divergence pair
ANIX DH
ANIX vs DH: by the numbers
- •DH is the larger company ($104M vs $100M market cap).
- •Both run net losses; ANIX's is the smaller (0.00% vs -72.28% net margin).
Metrics side by side
Valuation
| Metric | ANIX | DH |
|---|---|---|
| Forward P/E | N/A | 5.06 |
| P/S ratio | N/A | 0.45 |
| P/B ratio | 6.94 | 0.72 |
| EV / EBITDA | N/A | 0.48 |
| FCF yield | N/A | 27.45% |
Profitability
| Metric | ANIX | DH |
|---|---|---|
| Gross margin | 0.00% | 71.67% |
| Operating margin | 0.00% | -8.52% |
| Net margin | 0.00% | -72.28% |
| ROE | -72.02% | -116.28% |
| ROIC | -82.35% | 41.64% |
Growth (annualized)
| Metric | ANIX | DH |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 10.62% |
| FCF CAGR (5Y) | N/A | 2.14% |
| Total return CAGR (5Y) | -8.26% | -52.54% |
Frequently asked
- How have ANIX and DH total returns compared?
- Over the past 5 years, ANIX delivered -8.26% and DH delivered -52.54% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Anixa Biosciences ROEDefinitive Healthcare ROEAnixa Biosciences operating marginDefinitive Healthcare operating marginAnixa Biosciences revenue growthDefinitive Healthcare revenue growthAnixa Biosciences free cash flowDefinitive Healthcare free cash flow
Anixa Biosciences & Definitive Healthcare appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.